Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice.
Mol Ther. 2024 May 1;32(5):1359-1372. doi: 10.1016/j.ymthe.2024.02.033. Epub 2024 Feb 29.
Mol Ther. 2024.
PMID: 38429929
Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3.
Schuster KH, DiFranco DM, Putka AF, Mato JP, Jarrah SI, Stec NR, Sundararajan VO, McLoughlin HS.
Schuster KH, et al.
Front Neurosci. 2023 Feb 15;17:1118429. doi: 10.3389/fnins.2023.1118429. eCollection 2023.
Front Neurosci. 2023.
PMID: 36875652
Free PMC article.
Item in Clipboard
Impaired Oligodendrocyte Maturation Is an Early Feature in SCA3 Disease Pathogenesis.
Schuster KH, Zalon AJ, Zhang H, DiFranco DM, Stec NR, Haque Z, Blumenstein KG, Pierce AM, Guan Y, Paulson HL, McLoughlin HS.
Schuster KH, et al.
J Neurosci. 2022 Feb 23;42(8):1604-1617. doi: 10.1523/JNEUROSCI.1954-20.2021. Epub 2022 Jan 18.
J Neurosci. 2022.
PMID: 35042771
Free PMC article.
Item in Clipboard
Cite
Cite